Nasdaq auph.
The average twelve-month price prediction for Aurinia Pharmaceuticals is $14.00 with a high price target of $15.00 and a low price target of $13.00. Learn more on AUPH's analyst rating history. Do Wall Street analysts like Aurinia Pharmaceuticals more than its competitors?
Anyone who held Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) over the last year knows what a loser feels like. The share price has slid 66% in that time. On the bright side, the stock is actually up 50%With the business potentially at an important milestone, we thought we'd take a closer look at Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) future prospects. Aurinia Pharmaceuticals Inc., a ...Earnings vs Market: AUPH is forecast to become profitable over the next 3 years, which is considered above average market growth. High Growth Earnings: AUPH …Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today provided an update on its business performance. Preliminary unaudited net revenue for the three months and full year ...H.C. Wainwright analyst Ed Arce maintained a Buy rating on Aurinia Pharmaceuticals (NASDAQ: AUPH) on Friday, setting a price target of $35, which is approximately 142.38% above the present share ...
Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Aurinia Pharmaceuticals Inc. (AUPH) NasdaqGM - NasdaqGM Real Time Price. Currency in USD Follow 2W 10W 9M 9.06 +0.42 (+4.86%) At close: 04:00PM EST 8.94 -0.12 (-1.32%) After hours: 07:59PM EST 1d Gainers Astra Space, Inc. (NASDAQ: ASTR) rose 39.6% to $13.30 in pre-market trading after declining around 3% on Friday. Astra Space recently reported a Q3 loss of $0.06 per share.
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today provided an update on its business performance. Preliminary unaudited net revenue for the three months and full year ...
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced the filing of a registration statement on Form S-8 with the United States Securities and Exchange Commission ...Nike, Inc. has no single specific owner. According to Nasdaq, the company is a publicly traded one, with its shares listed on the New York Stock Exchange under the symbol NKE. As of May, 2014, 83.29 percent of Nike’s shares were owned by in...Perusahaan melaporkan laba per saham sebesar $-0,09 dan pendapatan sebesar $40,8M. Survei EPS dari analis Investing.com diharapkan sesuai perkiraan yang dirilis sebesar $-0,17 dengan laba $38,44M. Untuk tahun ini, saham Aurinia Pharma naik 65%, unggul kuat Nasdaq yang naik 24% dalam setahun hingga hari ini.Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) Q3 2023 Earnings Call Transcript November 2, 2023 Aurinia Pharmaceuticals Inc. beats earnings expectations. …Instrument Name Aurinia Pharm Ord Instrument Symbol (AUPH-Q). Instrument Exchange NASDAQ · Why Aurinia Pharmaceuticals Stock Is Slumping Today · Why Aurinia ...
About Latest Pre-Market Trades. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day.
2 analysts have issued twelve-month price targets for Aurinia Pharmaceuticals' stock. Their AUPH share price targets range from $13.00 to $15.00. On average, they expect the company's stock price to reach $14.00 in the next year. This suggests a possible upside of 62.8% from the stock's current price. View analysts price targets for AUPH or ...
Price. 9.06. +4.86%. Webull offers AUPH Ent Holdg (AUPH) historical stock prices, in-depth market analysis, NASDAQ: AUPH real-time stock quote data, in-depth charts, free AUPH options chain data, and a fully built financial calendar to help you invest smart. Buy AUPH stock at Webull. Aurinia Pharmaceuticals ( AUPH 3.43%), a small-cap commercial-stage drugmaker, is having another strong session today. Specifically, the biotech's stock was up by 11.9% on moderate volumes as of 1 ...AUPH: The Nasdaq Global Market LLC: AURINIA PHARMACEUTICALS INC. AND SUBSIDIARIES. TABLE OF CONTENTS. Page: PART I. FINANCIAL INFORMATION. 1. Item 1. Financial Statements (Unaudited) 1. Condensed Consolidated Balance Sheets (unaudited) as of September 30, 2023 and December 31, 202 2. 1.We feel now is a pretty good time to analyse Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) business as it appears the company may be on the cusp of a …Ocular Therapeutix Inc (NASDAQ:OCUL) has a beta value of 0.88 and has seen 1.29 million shares traded in the recent trading session. The company, currently valued at $262.48M, closed the recent trade at $3.31 per share which meant it gained $0.63 on the day or 23.32% during that session. ... (NASDAQ:AUPH) has a beta value of 1.39 and …Mar 9, 2023 · 9.24. +0.64. +7.44%. Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2022 Earnings Call Transcript February 28, 2023 Operator: Greetings, and welcome to the Aurinia Pharmaceuticals Fourth Quarter ...
It has been quite some time since we last took a look at Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH). This small biopharma has been somewhat of a roller coaster ride for its shareholders in recent ...Jun 16, 2023 · Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is a good speculative biotech play to look into. That's because it already has received FDA approval of LUPKYNIS™ as an oral treatment for adult ... During the last session, Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)’s traded shares were 2.07 million, with the beta value of the company hitting 1.26. At the end of the trading day, the stock’s price was $8.64, reflecting an intraday gain of 0.47% or $0.04. The 52-week high for the AUPH share is ...msn.com - August 8 at 2:56 PM. Jump Financial LLC Takes $366,000 Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) marketbeat.com - August 8 at 5:21 AM. Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) to Post Q1 2024 Earnings of ($0.14) Per Share, Leerink Partnrs Forecasts. marketbeat.com - August 7 at 7:47 AM.May 9, 2022 · In trading on Monday, shares of Aurinia Pharmaceuticals Inc (Symbol: AUPH) entered into oversold territory, hitting an RSI reading of 28.7, after changing hands as low as $8.86 per share. By ... It has been quite some time since we last took a look at Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH). This small biopharma has been somewhat of a roller coaster ride for its shareholders in recent ...
Dec 4, 2023 · December 4, 2023. Company. Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) has a beta value of 1.39 and has seen 0.72 million shares traded in the recent trading session. The company, currently valued at $1.27B, closed the recent trade at $8.82 per share which meant it lost -$0.24 on the day or -2.60% during that session. What happened. Shares of the autoimmune specialist Aurinia Pharmaceuticals ( AUPH 2.09%) rose by as much as 13.2% in early morning trading Friday. The biotech's shares cooled off after their hot ...
Back to AUPH Overview. Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or ... Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (Aurinia or the Company), a biopharmaceutical company committed to delivering therapeutics that change the trajectory of autoimmune disease, announced ...Nasdaq Insider Activity page provides trading information of corporate insiders (officers, directors and any beneficial owners of more than 10% of a class of the company’s equity securities). An ...Avid Bioservices Inc (NASDAQ:CDMO)’s Major holders. Insiders own 0.82% of the company shares, while shares held by institutions stand at 108.12% with a share float percentage of 109.02%. Investors are also buoyed by the number of investors in a company, with Avid Bioservices Inc having a total of 253 institutions that hold shares in the company.May 9, 2022 · In trading on Monday, shares of Aurinia Pharmaceuticals Inc (Symbol: AUPH) entered into oversold territory, hitting an RSI reading of 28.7, after changing hands as low as $8.86 per share. By ... Aurinia Pharmaceuticals 22.3 mln share stock offering priced at $6.75, 36% below Monday's closing price. Mar. 14, 2017 at 8:04 a.m. ET by Tomi Kilgore.Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Aurinia Pharmaceuticals ( NASDAQ: AUPH) traded ~5% higher pre-market Thursday after the Canadian biotech increased its full-year guidance and posted better-than-expected financials for Q2 2023 ...Dec 4, 2023 · December 4, 2023. Company. Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) has a beta value of 1.39 and has seen 0.72 million shares traded in the recent trading session. The company, currently valued at $1.27B, closed the recent trade at $8.82 per share which meant it lost -$0.24 on the day or -2.60% during that session.
Skip to main content. Market Activity. ->. Funds + ETFs. After-Hours Quotes. See All Market Activity->.
Aurinia AUPH announced that it has acquired two new pipeline candidates, which will target rare autoimmune and kidney-related diseases. Both the candidates, renamed as AUR200 and AUR300 following ...
Instrument Name Aurinia Pharm Ord Instrument Symbol (AUPH-Q). Instrument Exchange NASDAQ · Why Aurinia Pharmaceuticals Stock Is Slumping Today · Why Aurinia ...Find the latest Financials data for Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) at Nasdaq.com.Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q3 2023 Earnings Call Transcript November 2, 2023 Aurinia Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.09, expectations were $-0.17. Operator: Greetings. Welcome to Aurinia Pharmaceuticals Third Quarter 2023 Earnings Call. At this time, all participants are in a …... Nasdaq 5635(c)(4) · Все публикации. Обсуждение. Чтобы оставить комментарий ... Как купить AUPH (Aurinia Pharmaceuticals Inc) физическому лицу? Акции AUPH ...Aurinia Pharmaceuticals (NASDAQ:AUPH) Third Quarter 2022 ResultsKey Financial Results. Revenue: US$55.8m (up 280% from 3Q 2021). Net loss: US$8.99m (loss narrowed by 82% from 3Q 2021). US$0.063 ...Canadian biotech Aurinia Pharmaceuticals ( NASDAQ: AUPH) jumped ~11% pre-market Wednesday after announcing that the company is on track to receive two new patents in the U.S. and EU covering its ...Aurinia AUPH announced that it has acquired two new pipeline candidates, which will target rare autoimmune and kidney-related diseases. Both the candidates, renamed as AUR200 and AUR300 following ...In a report released on March 1, Joseph Schwartz from SVB Securities reiterated a Buy rating on Aurinia Pharmaceuticals (AUPH – Research R... In a report released on March 1, Joseph Schwartz from SVB Securities reiterated a Buy rating...Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) Option Chain | Nasdaq. Call and put options are quoted in a table called a chain sheet. The chain sheet shows the price, volume and open interest ...NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that...Home AUPH • NASDAQ Aurinia Pharmaceuticals Inc Follow Share $9.06 After Hours: $9.03 (0.33%) -0.030 Closed: Dec 1, 7:57:38 PM GMT-5 · USD · NASDAQ · Disclaimer search …
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20)The Panera Bread Company is a public company that is traded on the NASDAQ stock market. The majority of its shareholders are financial institutions and mutual fund holders. The remaining shares are owned by direct holders of Panera Bread st...The new research reports from Fundamental Markets, available for free download at the links above, examine Shinhan Financial Group Co Ltd (NYSE:SHG), Aurinia Pharmaceuticals Inc (NASDAQ:AUPH ...About Latest Pre-Market Trades. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day.Instagram:https://instagram. fast tv channelsvanguard short term bonds etfklaviyo ipo stock pricetraining for share trading Aurinia Pharmaceuticals ( AUPH 3.43%), a small-cap commercial-stage drugmaker, is having another strong session today. Specifically, the biotech's stock was up by 11.9% on moderate volumes as of 1 ...The latest price target for . Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by HC Wainwright & Co. on September 22, 2023.The analyst firm set a price target for $15.00 expecting AUPH to rise ... crackle barrel stockbest forex vps Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) Option Chain | Nasdaq. Call and put options are quoted in a table called a chain sheet. The chain sheet shows the price, volume and open interest ... tttxx stock Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares are trading higher, adding to gains of more than 17% over the last week.Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) is a speculative stock and it's not making any money, said Cramer. He prefers Nokia (NYSE:NOK) over Ericsson (NASDAQ:ERIC).The latest price target for . Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by HC Wainwright & Co. on September 22, 2023.The analyst firm set a price target for $15.00 expecting AUPH to rise ...